ERAS Erasca Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ERAS

Price (delayed)

$13.945

Market cap

$4.88B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.95

Enterprise value

$4.88B

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 2
Highlights
The debt is down by 10% year-on-year and by 2.7% since the previous quarter
The company's net income has shrunk by 124% YoY and by 3.7% QoQ
Erasca's EPS has shrunk by 121% YoY and by 2.2% QoQ
Sector: Healthcare
Industry: Biotechnology
Website: https://www.erasca.com
Peers: OLMA OMER VIVS ORIC

Key stats

What are the main financial stats of ERAS

ERAS stock price

How has the Erasca stock price performed over time
Intraday
-10.32%
1 week
-9.21%
1 month
-20.9%
1 year
687.85%
YTD
274.87%
QTD
-23.88%

Financial performance

How have Erasca's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$302.68M
Net income
-$287.22M
Gross margin
N/A
Net margin
N/A
The company's net income has shrunk by 124% YoY and by 3.7% QoQ
The company's operating income has shrunk by 106% YoY and by 3.2% QoQ

Price vs fundamentals

How does ERAS's price correlate with its fundamentals

Growth

What is Erasca's growth rate over time

Valuation

What is Erasca stock price valuation
P/E
N/A
P/B
11.98
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Erasca's EPS has shrunk by 121% YoY and by 2.2% QoQ
The P/B is 59% more than the last 4 quarters average of 8.4
The equity has declined by 8% since the previous quarter and by 2.8% year-on-year

Efficiency

How efficient is Erasca business performance
Erasca's return on equity has shrunk by 158% YoY and by 4.4% QoQ
ERAS's return on invested capital has dropped by 155% year-on-year and by 3.5% since the previous quarter
ERAS's ROA has dropped by 155% year-on-year and by 4.4% since the previous quarter

Dividends

What is ERAS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ERAS.

Financial health

How did Erasca financials performed over time
The current ratio has decreased by 25% YoY and by 13% QoQ
ERAS's quick ratio is down by 25% YoY and by 12% QoQ
The debt is 88% smaller than the equity
The debt is down by 10% year-on-year and by 2.7% since the previous quarter
The debt to equity has decreased by 8% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.